Dalong Zhu Selected Research

Fatty Liver

8/2019	Erythropoietin suppresses hepatic steatosis and obesity by inhibiting endoplasmic reticulum stress and upregulating fibroblast growth factor 21.
1/2018	Hepatic and cardiac beneficial effects of a long-acting Fc-apelin fusion protein in diet-induced obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dalong Zhu Research Topics

Disease

60	Type 2 Diabetes Mellitus (MODY) 05/2024 - 05/2008
22	Insulin Resistance 09/2023 - 08/2011
15	Obesity 09/2023 - 10/2013
14	Body Weight (Weight, Body) 12/2023 - 01/2013
12	Inflammation (Inflammations) 09/2023 - 10/2009
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 05/2012
9	Non-alcoholic Fatty Liver Disease 01/2020 - 02/2016
8	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 05/2008
8	Weight Loss (Weight Reduction) 09/2023 - 09/2015
8	Glucose Intolerance 01/2018 - 03/2010
6	Hypertension (High Blood Pressure) 11/2023 - 01/2013
6	Hyperglycemia 01/2021 - 02/2011
6	Weight Gain 01/2021 - 05/2008
4	Peripheral Nervous System Diseases (PNS Diseases) 11/2023 - 01/2021
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2021 - 07/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 10/2013
3	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 01/2023
3	Myocardial Infarction 11/2023 - 09/2018
3	Liver Diseases (Liver Disease) 12/2022 - 01/2016
3	Heart Failure 01/2021 - 01/2018
3	Fibrosis (Cirrhosis) 01/2021 - 01/2018
3	Atherosclerosis 01/2020 - 10/2009
3	Carotid Artery Diseases 01/2020 - 10/2009
3	Neoplasms (Cancer) 11/2019 - 08/2017
3	Dyslipidemias (Dyslipidemia) 03/2019 - 01/2013
3	Diabetes Complications 03/2019 - 12/2012
3	Prediabetic State (Prediabetes) 01/2018 - 03/2010
2	Chronic Renal Insufficiency 12/2023 - 01/2021
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 01/2017
2	Necrosis 01/2023 - 08/2017
2	Overweight 06/2022 - 01/2019
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 12/2020 - 01/2020
2	Endotoxemia 01/2020 - 07/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020 - 11/2019
2	Fatty Liver 08/2019 - 01/2018
2	Hyperandrogenism 01/2019 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2014 - 05/2013
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2012 - 07/2012
1	Hyperkalemia 12/2023
1	Nausea 12/2023

Drug/Important Bio-Agent (IBA)

33	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 03/2010
32	Insulin (Novolin)FDA Link 03/2024 - 05/2008
18	Blood Glucose (Blood Sugar)IBA 03/2023 - 05/2008
13	Metformin (Glucophage)FDA LinkGeneric 06/2022 - 05/2013
10	LipidsIBA 01/2021 - 09/2014
6	Hypoglycemic Agents (Hypoglycemics)IBA 04/2020 - 12/2015
5	Insulin Glargine (Lantus)FDA Link 12/2023 - 04/2018
5	NAD (NADH)IBA 11/2023 - 01/2021
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2023 - 06/2012
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2014
5	Erythropoietin FDA Link 08/2019 - 01/2013
4	DorzagliatinIBA 01/2022 - 01/2017
4	Triglycerides (Triacylglycerol)IBA 06/2021 - 10/2014
4	AutoantibodiesIBA 01/2019 - 01/2015
4	AndrogensIBA 01/2019 - 01/2018
4	Exenatide (Byetta)FDA Link 09/2017 - 10/2014
4	Sterol Regulatory Element Binding Protein 1IBA 07/2017 - 03/2014
3	Uric Acid (Urate)IBA 11/2023 - 01/2021
3	C-PeptideIBA 11/2023 - 12/2016
3	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2021
3	Therapeutic UsesIBA 05/2022 - 10/2014
3	LDL CholesterolIBA 01/2021 - 09/2014
3	SilymarinIBA 01/2021 - 01/2016
3	lixisenatideIBA 01/2021 - 01/2018
3	ProlactinIBA 01/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2010
3	ElementsIBA 06/2015 - 03/2014
3	SterolsIBA 06/2015 - 03/2014
3	ORALIT (ORS)IBA 01/2014 - 07/2012
2	dulaglutideIBA 01/2024 - 12/2023
2	finerenoneIBA 12/2023 - 01/2023
2	oxidized low density lipoproteinIBA 04/2023 - 01/2021
2	CholesterolIBA 04/2023 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2018
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2022 - 11/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2022 - 09/2017
2	LY2963016 insulin glargineIBA 01/2022 - 01/2021
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 02/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 07/2012
2	Hemoglobins (Hemoglobin)IBA 10/2020 - 11/2019
2	Liraglutide FDA Link 01/2020 - 08/2017
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 01/2018
2	OsteocalcinIBA 01/2018 - 12/2015
2	Testosterone (Sustanon)FDA Link 01/2018 - 01/2016
2	ApelinIBA 01/2018 - 01/2018
2	CytokinesIBA 09/2017 - 01/2015
2	Phosphotransferases (Kinase)IBA 08/2017 - 10/2013
2	AMP-Activated Protein KinasesIBA 07/2017 - 06/2015
2	Pioglitazone (Actos)FDA Link 12/2015 - 10/2014
2	Glipizide (Glucotrol)FDA LinkGeneric 10/2014 - 05/2013
1	insulin degludecIBA 03/2024

Therapy/Procedure

25	Therapeutics 12/2022 - 05/2008
9	Glycemic Control 03/2024 - 05/2010
5	Bariatric Surgery 09/2023 - 01/2018
5	Hematopoietic Stem Cell Transplantation 09/2014 - 05/2012
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 09/2023 - 01/2019
2	Gastrectomy 09/2023 - 05/2022
2	Transplantation 01/2022 - 12/2016